TBIO
Income statement / Annual
Last year (2023), Telesis Bio, Inc.'s total revenue was $27.51 M,
an increase of 0.27% from the previous year.
In 2023, Telesis Bio, Inc.'s net income was -$47.72 M.
See Telesis Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$27.51 M
|
$27.44 M
|
$11.04 M
|
$6.58 M
|
$4.81 M
|
$1.42 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$14.66 M |
$11.84 M |
$6.74 M |
$2.95 M |
$8.89 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$12.85 M |
$15.60 M |
$4.30 M |
$3.63 M |
-$4.08 M |
$1.42 M |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.47 |
0.57 |
0.39 |
0.55 |
-0.85 |
1 |
0 |
0 |
| Research and Development
Expenses |
$17.50 M
|
$23.46 M
|
$14.55 M
|
$8.93 M
|
$1.32 M
|
$58.02 M
|
$47.02 M
|
$15.66 M
|
| General & Administrative
Expenses |
$21.09 M
|
$22.13 M
|
$14.23 M
|
$4.13 M
|
$4.69 M
|
$22.61 M
|
$14.31 M
|
$11.14 M
|
| Selling & Marketing
Expenses |
$13.51 M
|
$16.49 M
|
$10.90 M
|
$6.93 M
|
$2.25 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$30.50 M
|
$38.62 M
|
$25.13 M
|
$11.06 M
|
$1.57 M
|
$22.61 M
|
$14.31 M
|
$11.14 M
|
| Other Expenses |
-$130,000.00 |
-$26,000.00 |
-$62,000.00 |
-$74,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$48.00 M |
$62.08 M |
$39.67 M |
$19.99 M |
$2.89 M |
$80.63 M |
$61.33 M |
$26.80 M |
| Cost And Expenses |
$62.66 M |
$73.92 M |
$46.42 M |
$22.94 M |
$11.78 M |
$80.63 M |
$61.33 M |
$26.80 M |
| Interest Income |
$1.74 M |
$1.22 M |
$1.37 M |
$690,000.00 |
$1.79 M |
$1.32 M |
$281,000.00 |
$114,000.00 |
| Interest Expense |
$3.11 M |
$1.22 M |
$1.37 M |
$690,000.00 |
$1.49 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$4.10 M
|
$2.88 M
|
$1.57 M
|
$1.46 M
|
$857,000.00
|
$2.84 M
|
$1.59 M
|
$730,000.00
|
| EBITDA |
-$31.05 M
|
-$46.51 M
|
-$33.86 M
|
-$14.98 M
|
-$6.12 M
|
-$100.12 M
|
-$77.34 M
|
-$25.97 M
|
| EBITDA Ratio |
-1.13 |
-1.7 |
-3.07 |
-2.28 |
-1.27 |
-70.51 |
0 |
0 |
| Operating Income Ratio
|
-1.28
|
-1.69
|
-3.2
|
-2.49
|
-1.45
|
-72.51
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$12.55 M
|
-$1.96 M
|
-$3.57 M
|
-$1.64 M
|
-$1.33 M
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$47.70 M |
-$48.45 M |
-$38.94 M |
-$18.01 M |
-$8.30 M |
-$102.96 M |
-$78.92 M |
-$26.70 M |
| Income Before Tax Ratio
|
-1.73
|
-1.77
|
-3.53
|
-2.74
|
-1.73
|
-72.51
|
0
|
0
|
| Income Tax Expense |
$24,000.00 |
$24,000.00 |
$14,000.00 |
$5,000.00 |
-$486,000.00 |
-$5.57 M |
-$12.48 M |
$707,184.00 |
| Net Income |
-$47.72 M |
-$48.47 M |
-$38.96 M |
-$18.01 M |
-$8.30 M |
-$97.40 M |
-$66.44 M |
-$26.70 M |
| Net Income Ratio |
-1.73 |
-1.77 |
-3.53 |
-2.74 |
-1.73 |
-68.59 |
0 |
0 |
| EPS |
-1.6 |
-1.65 |
-1.33 |
-0.62 |
-0.2 |
-2.16 |
-2.23 |
-0.89 |
| EPS Diluted |
-1.6 |
-1.65 |
-1.33 |
-0.62 |
-0.2 |
-2.16 |
-2.23 |
-0.89 |
| Weighted Average Shares
Out |
$29.85 M
|
$29.46 M
|
$29.32 M
|
$29.23 M
|
$40.76 M
|
$45.00 M
|
$29.86 M
|
$29.86 M
|
| Weighted Average Shares
Out Diluted |
$29.85 M
|
$29.46 M
|
$29.32 M
|
$29.23 M
|
$40.76 M
|
$45.00 M
|
$29.86 M
|
$29.86 M
|
| Link |
|
|
|
|
|
|
|
|
